• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of Anticancer drugs sensitivity test evaluable for short period of time by flow cytometry

Research Project

Project/Area Number 61570752
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Urology
Research InstitutionTOHOKU UNIVERSITY

Principal Investigator

YOSHIKAWA Kazuyuki  Department of Urology, Tohoku University School of Medicine, 医学部, 助手 (10133977)

Co-Investigator(Kenkyū-buntansha) HOSHI Senji  Department of Urology, Tohoku University School of Medicine, 医学部付属病院, 助手 (80107200)
Project Period (FY) 1986 – 1987
Project Status Completed (Fiscal Year 1987)
Budget Amount *help
¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 1987: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 1986: ¥1,200,000 (Direct Cost: ¥1,200,000)
KeywordsAnticancer drugs sensitivity test / フローサイトメトリー
Research Abstract

We have tried to develop the anticancer drugs sensitivity test evaluable for short period of time by flow cytometry. Though the study schedule had been delayed by the mechanical troubles of the flow cytometer, following results were obtained. 1.Primary culture of renal, bladder and tisticular tumors were carried out on fairy well condition by mechanical cell dispersion and using a culture medium containing RPMI-1640 and 10% fetal calf serum. 2.The early morphological effects of anticancer drugs(Cisplatin and-Adriamicin) on cancer cells were destruction and condensation of nuculei, and these findings were found within 24 hours. 3.Changes of DNA histogram of cancer cells by anticancer drugs were found earlier than morphological one. But not a few cases of renal and bladder cancer showed DNA polyploidy. As for cell cycle analysis, the programs only for monoclone DNA histogram were available, so limited cases could be analyzed actually. Cell cycle analysis using anti-BrdU antibody was needed for those polyclonal cases. To find the analysis conditions suitable for urologic cancer is in progress. 4.The ATP contents could be measured by Luminophotometer that required as little as 1 x 10^4 cells per determination, and were correlated with viablity by trypan blue. This method is simple and quick to determine the cell viablity.
The first aim of this study to elucidate the changes of the DNA histogram, cell cycle and cell morphology from the time of anticancer drugs contact to cell death compared with each other simultanuously, and apply anticancer drugs sensitivity test has not completed, for unexpected prolonged machinary troubles of flow cytometer. This study will continue, and enable us to develop the unique anticancer drugs sensitivitiy test evaluable for short period.

Report

(2 results)
  • 1987 Final Research Report Summary
  • 1986 Annual Research Report
  • Research Products

    (6 results)

All Other

All Publications (6 results)

  • [Publications] 吉川和行: 日本泌尿器科学会雑誌. 78. 227-231 (1987)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1987 Final Research Report Summary
  • [Publications] 吉川和行: 日本泌尿器科学会雑誌.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1987 Final Research Report Summary
  • [Publications] Kazuyuki Yoshikawa: "Study on bladder cancer by flow cytometry II Evaluation of prognosis and intravesical recurrence of bladder cancer based on flow cytometric DNA analysis" Japanese Journal of Urology. 78. 227-231 (1987)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1987 Final Research Report Summary
  • [Publications] Kazuyuki Yoshikawa: "Analysis of renal cell carcinoma by flow cytometric DNA analysis" Japanese Journal of Urology.

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1987 Final Research Report Summary
  • [Publications] 吉川和行: 日本泌尿器科学会雑誌.

    • Related Report
      1986 Annual Research Report
  • [Publications] 吉川和行: 日本泌尿器科学会雑誌.

    • Related Report
      1986 Annual Research Report

URL: 

Published: 1987-03-31   Modified: 2025-11-20  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi